Concussion/Mild Traumatic Brain Injury

Despite the brain being one of the most important organs of the body, breakthroughs in brain health, specifically the way we measure cognition, have been largely unchanged in decades.

One of the challenges in diagnosing and managing mild traumatic brain injury is that common structural imaging techniques, such as computerized tomography or magnetic resonance imaging, typically don’t show any visible damage to the brain.

In this edition, blood-based concussion diagnostic tool gets patent; examining the brain’s electrical signals may be key to treating epilepsy, schizophrenia; machine-learning model may predict best antiseizure medications and more.

Canadian-based Neurolytixs Inc. announced it has secured a United States patent for technology that can identify mild traumatic brain injuries more accurately and rapidly, particularly in young athletes with concussions.